Turning Point Therapeutics Inc

NASDAQ:TPTX  
77.89
-0.71 (-0.90%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Turning Point Therapeutics Inc Stock, NASDAQ:TPTX

10628 Science Center Drive, Suite 200, San Diego, California 92121
United States of America
Phone: +1.858.926.5251
Number of Employees: 142

Description

Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by J. Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.